CIK 1747821
Long positions in SEC Section 13(f) securities (US-listed stocks, ADRs and ETFs), largest first · Δ vs 2023-Q2. A lagged quarterly snapshot (filed ≤45 days after quarter-end); excludes shorts, options, cash, and shares listed only on non-US exchanges — foreign companies held via a US listing or ADR (e.g. Alibaba, TSMC) ARE included.
As filed = each book applied at its quarter-end (what the reported book did) · As copyable = applied at its statutory 45-day filing deadline (what a 13F follower could have earned).
Computing…
Hypothetical modeled performance constructed with hindsight — not actual results, and not indicative of future results. See the Disclaimer.
| Industry group | Weight | Names |
|---|---|---|
| Pharmaceuticals & Biotechnology | 44.04% | 11 |
| Unclassified | 42.42% | 10 |
| Life Sciences Tools & Services | 12.73% | 3 |
| Health Care Equipment & Supplies | 0.68% | 1 |
| Health Care Providers & Services | 0.13% | 1 |
| # | Ticker | Name | Sector | Weight |
|---|---|---|---|---|
| 1 | ALPINE IMMUNE SCIENCES INC | Unclassified | 25.63% | |
| 2 | ZNTL | Zentalis Pharmaceuticals, Inc. | Health Care | 14.06% |
| 3 | AURA | Aura Biosciences, Inc. | Health Care | 6.09% |
| 4 | ROIV | Roivant Sciences Ltd. | Health Care | 5.69% |
| 5 | ACELYRIN INC | Unclassified | 5.26% | |
| 6 | RCUS | Arcus Biosciences, Inc. | Health Care | 5.21% |
| 7 | TXG | 10x Genomics, Inc. | Health Care | 4.95% |
| 8 | ARGX | Argenx SE | Health Care | 4.50% |
| 9 | PACB | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Health Care | 4.08% |
| 10 | ILMN | ILLUMINA, INC. | Health Care | 3.70% |
16/26 names classified · sector 57.6% of weight · industry 57.6% · mkt cap 53.1%; unclassified names shown, never dropped.
Sector is classified on each name's CURRENT fundamentals, not point-in-time — apparent sector drift can reflect the market re-rating a holding, not a manager trade. 13F is a lagged quarterly snapshot of long positions in US-listed securities only — foreign companies held via a US listing or ADR ARE included, but shares listed only on non-US exchanges (plus shorts, options and cash) are not. Latest quarter: 57.6% of the book is sector-classified (unclassified names shown, never dropped).
Only 8% of book weight classified — the grid is NOT representative of the whole book.
Classified: 7.9% of book weight (3/20 names) · unclassified 92.1%: , ZNTL, AURA, ROIV, RCUS, TXG, ARGX, PACB, PHAT, HLTHQ +7 more. Size: cap 70/20/10 bands; style: value/growth composite on our own metrics — not Morningstar's model.
No contribution data for this period.
| # | Security | Shares | Value | Weight | Δ QoQ |
|---|---|---|---|---|---|
| 1 | ALPINE IMMUNE SCIENCES INC | 6,708,288 | $77M | 25.6% | NEW |
| 2 | ZNTLZENTALIS PHARMACEUTICALS INC | 2,099,583 | $42M | 14.1% | HOLD |
| 3 | AURAAURA BIOSCIENCES INC | 1,163,123 | $18M | 6.1% | ADD 297% |
| 4 | ROIVROIVANT SCIENCES LTD | 1,459,700 | $17M | 5.7% | NEW |
| 5 | ACELYRIN INC | 1,548,317 | $16M | 5.3% | HOLD |
| 6 | RCUSARCUS BIOSCIENCES INC | 869,790 | $16M | 5.2% | HOLD |
| 7 | TXG10X GENOMICS INC | 359,554 | $15M | 4.9% | HOLD |
| 8 | ARGXARGENX SE | 27,429 | $13M | 4.5% | HOLD |
| 9 | PACBPACIFIC BIOSCIENCES CALIF IN | 1,463,872 | $12M | 4.1% | HOLD |
| 10 | ILMNILLUMINA INC | 80,859 | $11M | 3.7% | HOLD |
| 11 | LNTHLANTHEUS HLDGS INC | 142,196 | $10M | 3.3% | NEW |
| 12 | HORIZON THERAPEUTICS PLC | 78,900 | $9M | 3.0% | HOLD |
| 13 | PHATPHATHOM PHARMACEUTICALS INC | 850,000 | $9M | 2.9% | HOLD |
| 14 | IMMUNOGEN INC | 415,880 | $7M | 2.2% | NEW |
| 15 | SEAGEN INC | 23,014 | $5M | 1.6% | NEW |
| 16 | HLTHQCUE HEALTH INC | 8,980,909 | $4M | 1.3% | HOLD |
| 17 | BYSIBEYONDSPRING INC | 4,958,143 | $4M | 1.3% | NEW |
| 18 | TERNS PHARMACEUTICALS INC | 714,285 | $4M | 1.2% | HOLD |
| 19 | EQEQUILLIUM INC | 4,447,308 | $3M | 1.1% | HOLD |
| 20 | WHWKWHITEHAWK THERAPEUTICS INC | 526,329 | $3M | 0.9% | HOLD |
| 21 | ATRCATRICURE INC | 46,259 | $2M | 0.7% | NEW |
| 22 | SCYXSCYNEXIS INC | 555,555 | $1M | 0.4% | HOLD |
| 23 | MERSANA THERAPEUTICS INC COM | 904,268 | $1M | 0.4% | HOLD |
| 24 | PYXSPYXIS ONCOLOGY INC | 326,810 | $650,352 | 0.2% | NEW |
| 25 | WGSGENEDX HOLDINGS CORP | 103,604 | $377,118 | 0.1% | NEW |
| 26 | ACETADICET BIO INC | 200,201 | $274,275 | 0.1% | TRIM −60% |
Where this firm's principals came from and which firms its alumni went on to found.
